Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,822 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a generic wound care assessment minimum data set.
Coleman S, Nelson EA, Vowden P, Vowden K, Adderley U, Sunderland L, Harker J, Conroy T, Fiori S, Bezer N, Holding E, Atkin L, Stables E, Dumville J, Gavelle S, Sandoz H, Moore K, Chambers T, Napper S, Nixon J; Improving Wound Care Project Board, as part of NHS England's Leading Change Adding Value Framework. Coleman S, et al. Among authors: moore k. J Tissue Viability. 2017 Nov;26(4):226-240. doi: 10.1016/j.jtv.2017.09.007. Epub 2017 Sep 18. J Tissue Viability. 2017. PMID: 29030056 Free article. Review.
A strategy to reduce the carbon footprint of clinical trials.
Adshead F, Al-Shahi Salman R, Aumonier S, Collins M, Hood K, McNamara C, Moore K, Smith R, Sydes MR, Williamson PR. Adshead F, et al. Among authors: moore k. Lancet. 2021 Jul 24;398(10297):281-282. doi: 10.1016/S0140-6736(21)01384-2. Epub 2021 Jun 23. Lancet. 2021. PMID: 34171294 No abstract available.
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
Sadun RE, Cooper JC, Belot A, Avcin T, Aggarwal A, Ainsworth J, Akinsete A, Ardoin SP, Beresford MW, Bortey L, Brunner HI, Chang JC, Ciurtin C, Daftary A, Eberhard B, Feldman CH, Hedrich CM, Hersh AO, Hiraki LT, Isenberg DA, Kamphuis S, Knight AM, Lambert L, Levy DM, Marks SD, Maxwell N, Migowa A, Moore K, Ozen S, Ramsey-Goldman R, Ravelli A, Reeve BB, Rubinstein TB, Saad-Magalhaes C, Sawhney S, Schanberg LE, von Scheven E, Scott C, Son MB, Tony G, Weitzman ER, Wenderfer SE, Woodside A, Lewandowski LB, Smith EM; CARRA SLE Committee and PReS Lupus Working Party. Sadun RE, et al. Among authors: moore k. Ann Rheum Dis. 2024 Oct 8:ard-2024-226528. doi: 10.1136/ard-2024-226528. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39379141
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.
Chang MH, Barbar-Smiley F, Akoghlanian S, Drew J, Angeles-Han ST, Quinlan-Waters M, Bohnsack JF, Cooper AM, Edelheit B, Twachtman-Bassett J, Lerman MA, Nanda K, Rabinovich CE, Lo MS; CARRA Uveitis Workgroup and the CARRA Registry Investigators. Chang MH, et al. Pediatr Rheumatol Online J. 2024 Oct 7;22(1):88. doi: 10.1186/s12969-024-01022-x. Pediatr Rheumatol Online J. 2024. PMID: 39375683 Free PMC article.
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer.
Grisham R, Monk BJ, Van Nieuwenhuysen E, Moore KN, Fabbro M, O'Malley DM, Oaknin A, Thaker P, Oza AM, Colombo N, Gershenson D, Aghajanian CA, Choi CH, Lee YC, Mirza MR, Coleman RL, Cobb L, Harter P, Lustgarten S, Youssoufian H, Banerjee S. Grisham R, et al. Among authors: moore kn. Int J Gynecol Cancer. 2024 Oct 7:ijgc-2024-005919. doi: 10.1136/ijgc-2024-005919. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 39375168
4,822 results